Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

Investing

Eli Lilly : LLY

All Eli Lilly Articles

680 Articles

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 7, 2017 at 10:35 AM EDT

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Eli Lilly is cutting about 8% of its global workforce in a "streamlining and focusing" effort as part of a…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jul 26, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

The top analyst upgrades, downgrades and other research calls from Wednesday include BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald's,…

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Lee Jackson | Jul 19, 2017 at 9:42 AM EDT

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 27, 2017 at 8:45 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 12, 2017 at 8:55 AM EDT

Short Sellers Grow More Selective on Major Pharma

The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 2, 2017 at 1:35 PM EDT

15 Companies Bracing for Big ASCO Reactions

24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could…

Chris Lange | May 27, 2017 at 8:40 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

1 … 25 26 27 28 29 … 46

Eli Lilly : LLY

All Eli Lilly Articles

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma

15 Companies Bracing for Big ASCO Reactions

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

Cash Pays 3.8% and the Fed May Hike. This T-Bill Fund Pays the Same but Sends No Tax Bill Until You Sell

The One Design Choice That Made JEPQ Crush JEPI, and Why It Can Flip Overnight

Reddit Is Still Down 24% This Year. What Will It Take to Get RDDT Stock Back Up to $200?

He Maintained a Neighborhood Bike Station for Free Rides. Social Security Could Count Them as Pay.

He Spent $10,000 Turning His Black Belt Into a Second Career. The IRS Called It a New Profession, Not a Deduction.

Cash Pays 3.8% and the Fed May Hike. This T-Bill Fund Pays the Same but Sends No Tax Bill Until You Sell

The One Design Choice That Made JEPQ Crush JEPI, and Why It Can Flip Overnight

Eli Lilly : LLY

All Eli Lilly Articles

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma

15 Companies Bracing for Big ASCO Reactions

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Live Nasdaq Composite: Markets Poised to Lock in Weekly Gains Amid AI Earnings-Powered Cycle

Cash Pays 3.8% and the Fed May Hike. This T-Bill Fund Pays the Same but Sends No Tax Bill Until You Sell

The One Design Choice That Made JEPQ Crush JEPI, and Why It Can Flip Overnight

Reddit Is Still Down 24% This Year. What Will It Take to Get RDDT Stock Back Up to $200?

Featured Reads

He Maintained a Neighborhood Bike Station for Free Rides. Social Security Could Count Them as Pay.

He Spent $10,000 Turning His Black Belt Into a Second Career. The IRS Called It a New Profession, Not a Deduction.